View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/FDA RIN: 0910-AH12 Publication ID: Fall 2014 
Title: Administrative Destruction of Certain Drugs Refused Admission to the United States  
Abstract:

The rule would provide the owner or consignee of a drug that has been refused admission into the United States and that is valued at $2,500 or less (or such higher amount as the Secretary of the Treasury may set by regulation) with written notice that FDA intends to destroy the drug and an opportunity to present testimony to the Agency before the drug is destroyed.

 
Agency: Department of Health and Human Services(HHS)  Priority: Substantive, Nonsignificant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1.94   
Legal Authority: 21 USC 381   
Legal Deadline:
Action Source Description Date
Final  Statutory    07/09/2014 
Timetable:
Action Date FR Cite
NPRM  05/06/2014  79 FR 25758   
NPRM Comment Period End  07/07/2014 
Final Action  09/00/2015 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Ann Marie Metayer
Regulatory Counsel
Department of Health and Human Services
Food and Drug Administration
10903 New Hampshire Avenue, Building 32, Room 4375,
Silver Spring, MD 20993
Phone:301 796-3324
Email: ann.metayer@fda.hhs.gov